VER-01 Expands cannabis-derived medicines Options
Erin J. Walsh explains how VER-01 could position cannabis-derived medicines in chronic pain care, urging standardized pharmaceutical testing and further
Tag: medicine
Germany Approves cannabis painkiller Exilby for Back Pain
cannabis painkiller Exilby wins German approval for chronic back pain; phase‑3 showed 1.9 vs 1.4 pain reduction, 17% discontinued; launch planned Sept 2026.
Aging cannabis users face increased health risks
As cannabis consumption becomes more prevalent among older adults, healthcare professionals are increasingly concerned about the associated health risks. Benjamin…
Cantourage thrives in Germany’s growing cannabis market
In Bavaria, Germany, Cantourage, a manufacturer and distributor of cannabis-based medical products, operates in a highly secure facility that emphasizes…
Howard University Study Examines Cannabis for Sickle Cell Treatment
As opioid prescriptions face stricter regulations, researchers at Howard University are investigating the use of cannabis as a treatment for…
Cannabis use doubles among older Americans, study finds
Marijuana use among Americans aged 65 and older is on the rise, with recent studies showing usage nearly doubling in…
Cannabis use among seniors rises, raising health concerns
Recent research indicates that cannabis use among older adults is climbing sharply. A study conducted by researchers at UC San…
Marijuana Use Among Seniors Reaches 7%, Impacting Nursing Homes
Marijuana use among seniors in the United States has reached an all-time high, with 7% of adults aged 65 and…
Germany’s cannabis industry thrives amid regulatory shifts
Germany is experiencing a surge in its medical cannabis sector, with companies like Cantourage leading the charge in producing and…
Cantourage expands cannabis production in Bavaria, Germany
In Bavaria, Germany, CEO Philip Schetter of Cantourage recently showcased the company’s cannabis production facility, which is secured by a…